KBV200细胞多药耐药与蛋白激酶C表达上调的关系

南方医科大学学报 ›› 2005, Vol. 25 ›› Issue (11): 1341-1343,1356.

KBV200细胞多药耐药与蛋白激酶C表达上调的关系

袁亚维¹, 孙爱民¹, 李传刚²

1. 南方医科大学南方医院放疗科, 广东, 广州, 510515;
2. 南方医科大学南方医院超声诊断科, 广东, 广州, 510515

出版日期:2005-11-20 发布日期:2005-11-20
基金资助:
收稿日期:2005-7-25。
基金项目:National Natural Science Foundation of China(39870809)
作者简介:YUANYa-wei,PhD,professor,Tel:86-20-61642135,E-mail:yuanyawei@fangliao.com

Correlation of multidrug resistance with up-regulation of protein kinase C expression in KBV200 cells

YUAN Ya-wei¹, SUN Ai-min¹, LI Chuan-gang²

1. 南方医科大学南方医院放疗科, 广东, 广州, 510515;
2. 南方医科大学南方医院超声诊断科, 广东, 广州, 510515

Online:2005-11-20 Published:2005-11-20

摘要/Abstract

摘要： 目的研究KBV200多药耐药细胞蛋白激酶C(PKC)的表达,探讨PKC的表达上调与肿瘤多药耐药的关系。方法 KBV200细胞分对照组和佛波酯(PMA)组,PMA组应用200nmol/L的PMA预孵育细胞,而对照组不用。³²P掺入法测定多药耐药KBV200细胞株的PKC活性,通过Westernblotting检测PKC各亚型表达和亚细胞分布。用MTT法检测细胞耐药性。结果 PMA预孵育可提高KBV200细胞的PKC总活性和膜组分PKC活性,降低浆组分PKC活性(P<0.01)。PMA预孵育使膜组分PKCα表达增加,浆组分PKCα表达降低,膜组分PKCβ无明显变化,浆组分PKCβ的表达稍增强。PMA可升高长春新碱、阿霉素对KBV200细胞的IC₅₀值(P<0.01)。结论 PMA使KBV200细胞耐药性增加,可能与PKC表达上调有关。

Abstract: Objective To investigate protein kinase C (PKC) expression and its association with multidrug resistance (MDR) in KBV200 cells. Methods KBV200 cells were preincubated with PKC activator phorbol-12-myristate-13-acetate (PMA, 200 nmol/L) and PKC activity was assayed by measurement of peptide substrate ³²P incorporation from [γ-³²P]ATP, with the cells without PMA preincubation serving as the control. Western blotting was performed for assessing the expression of PKC isoform, and the cell inhibition rate was evaluated by MTT assay. Results PMA preincubation of the cells significantly enhanced the activity of the total PKC and the membrane fraction, but lowered the PKC activity of the cytosol fraction, as compared with the cells without PMA treatment (P<0.01). PKCα expression was upregulated in the membrane fraction and down-regulated in the cytosol fraction in KBV200 cells after PMA preincubation. PKCβ expression was slightly elevated in the cytosol fraction but exhibited no obvious changes in the membrane fraction after PMA pretreatment of the cells. The values of IC₅₀ of vincristine and adriamycin in PMA-treated cells were increased to 2275.5 nmol/L and 233.25 nmol/L, respectively (P<0.01). Conclusion PMA can increase the multidrug resistance of KBV200 cells, which suggests the possible involvement of PKC in the mechanism of multidrug resistance of tumor cells.

中图分类号:

R730.53

袁亚维¹, 孙爱民¹, 李传刚². KBV200细胞多药耐药与蛋白激酶C表达上调的关系[J]. 南方医科大学学报, 2005, 25(11): 1341-1343,1356.

YUAN Ya-wei¹, SUN Ai-min¹, LI Chuan-gang². Correlation of multidrug resistance with up-regulation of protein kinase C expression in KBV200 cells[J]. Journal of Southern Medical University, 2005, 25(11): 1341-1343,1356.

参考文献

[1] 韩英,时永全,李玲,等.蛋白激酶C同工酶PKCα及βI在胃癌及其耐药细胞中的表达和功能[J].中华肿瘤杂志,2001,23(2):103-6.Han Y, Shi YQ, Li L, et al. Expression and function of PKC-α and β isoeymes in drug-resistance gastric cancer cell[J]. Chin J Oncol, 2001,23(2): 103-6.
[2] 孙爱民,袁亚维,李传刚,等.蛋白激酶C活性、亚细胞分布与KBV200细胞多药耐药的相关研究[J].第一军医大学学报,2002,22(2):121-3.Sun AM, Yuan YW, Li CG, et al. Correlation of protein kinase C activity and its subcellular distribution with multidrug resistance in KVB200 cells[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22(2): 121-3.
[3] 袁亚维,孙爱民,李传刚,等.KBV200细胞多药耐药与蛋白激酶C亚型表达的关系[J].第一军医大学学报,2002,22(3):215-9.Yuan YW, Sun AM, Li CG, et al. Correlation of protein kinase C isoform expression with multidrug resistance in KBV200 cells[J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22 (3):215-9.
[4] 张晓红,张福荣,籍秀娟,等.KB细胞耐药株的建立及其耐药机制的探讨[J].药学学报,1994,29(4):246-51.Zhang XH, Zhang FR, Ji XJ, et al. Vincristine-resistant human KB cell line and mechanism ofmultidrug resistance[J]. Acta Pharm Sin, 1994, 29 (4): 246-51.
[5] Karp JE. MDR modulation in acute myelogenous leukemia: is it dead[J] ? Leukemia, 2001, 15(4): 666-7.
[6] Blobe GC, Sachs CW, Khan WA, et al. Slective regulation of protein kinase C isoenzymes in multidrug-resistant MCF-7 cells[J]. J Biol Chem, 1993, 268(1): 658-64.
[7] Gravitt KR, Ward NE, Fan D, et al. Evidence that protein kinase C-activation is a critical event in phorbol esters induced multiple drug resistance in human colon cancer cells[J]. Biochem Pharmacol, 1994, 48 (2): 375-81.
[8] Schwartz GK, Arkin H, Holland JF, et al. Protein kinase Cactivity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cell resistant to trimetrexate[J]. Cancer Res, 1991, 51 (1):55-61.
[9] Gill PK, Gescher A, Gant TW. Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta[J]. Eur J Biochem, 2001,268 (15): 4151-7.
[10] Masanek U, Stammler G, Volm M. Modulation of multidrug resistance in human ovarian cancer cell lines by inhibition of P-glycoprotein 170 and PKC isoenzymes with antisense oligonucleotides[J]. J Exp Ther Oncol, 2002, 2(1): 37-41.